California · SELF-PACED COURSE
California: Naloxone Administration
- EMT
- AEMT
- Paramedic
Review California EMT naloxone education and device use; broader overdose care has a separate course.

60 minutesMinimum study time
20 lessons6 modules · Self-paced
12 monthsOf course access
Learning recordAfter required completion
COURSE OVERVIEW
Learning That Fits Your Schedule
Work through the lessons, required activities and knowledge checks. Your saved place lets you return between sessions. Complete the final assessment and evaluation to receive a learning completion record.
Online coursework does not replace supervised hands-on competency. Follow your scope of practice, local protocols and medical direction.
LEARNING OBJECTIVES
What You’ll Learn
- Distinguish California knowledge education, approved practical verification, public medication access and local EMS authority while preserving resuscitation priorities.
- Assess respiratory depression and interpret naloxone response without excluding alternative or mixed causes or mistaking awakening for effective ventilation.
- Verify the actual antagonist and delivery system and explain safe preparation, administration and further-dose decisions for the named single-use nasal product.
- Maintain pediatric and postresponse care, recognize recurrence and airway problems, communicate a reliable timeline and evaluate the integrated practical task.
- Develop written plans for progressive naloxone cases and document actual treatment, support and remaining professional, local, practical and CE requirements.
YOUR LEARNING PATH
Inside the Course
01California Education, Access and EMS Authority
02Respiratory Recognition and Response Interpretation
03Product Verification and Single-Dose Nasal Workflow
04Pediatric Care, Recurrence and Postreversal Symptoms
05Treatment Handoff, Continued Evaluation and Practical Readiness
06Progressive Cases and Evidence-Based Completion
CE approval & acceptance
This course currently awards 0 approved CE hours. Check acceptance details.
Course material is being revised. Clinical review is not yet complete.
